Skip to content

Hemodynamic Effects of BPA at Rest and During Exercise in CTEPH

An International Multicenter Observational Study to Assess the Hemodynamic Effects of Balloon Pulmonary Angioplasty (BPA) at Rest and During Exercise in Chronic Thromboembolic Pulmonary Hypertension (CTEPH) or Chronic Thromboembolic Pulmonary Disease (CTED) Patients (EXPERT-BPA)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04052243
Acronym
EXPERT-BPA
Enrollment
80
Registered
2019-08-09
Start date
2021-01-01
Completion date
2024-06-30
Last updated
2022-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Thromboembolic Pulmonary Hypertension

Brief summary

Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by obstruction of the pulmonary vasculature by residual organized thrombi, leading to increased pulmonary vascular resistance (PVR), progressive pulmonary hypertension, and right heart failure. Medical therapy and balloon angioplasty (BPA) are effective treatment alternatives in lowering pulmonary pressures and increasing pulmonary flow. The aim of this study is to assess the hemodynamic effects of BPA or medical therapy on the pressure-flow relationship in the pulmonary vasculature and the pulmonary vascular compliance.

Detailed description

Chronic thromboembolic pulmonary hypertension \[CTEPH\] is a rare condition with a significant risk of morbidity and mortality. The primary cause of CTEPH is thrombotic lesions, which did not resolve after acute pulmonary embolism. This causes increased pulmonary vascular resistance \[PVR\], leading to secondary remodeling of pulmonary arteries causing pulmonary hypertension and ultimately progressive right heart failure. The treatment of choice is surgical pulmonary endarterectomy \[PEA\], however up to 40% cases are not treated surgically, due to operability, anatomic location of the lesions, patient choice and comorbidities significantly increasing procedural risk. A new alternative procedure, balloon pulmonary angioplasty \[BPA\] has been proposed for patients with inoperable CTEPH or persistent pulmonary hypertension after pulmonary endarterectomy (PEA) and is currently characterized with good outcome in functional capacity, hemodynamic parameters, biomarkers, and health-related quality of life. Exercise stress tests of the pulmonary circulation are used in workup and diagnosis of pulmonary hypertension as a hemodynamic abnormality. The approach has allowed identification of patients with normal or marginally increased mPAP at rest but with symptomatic increases in mPAP at exercise, related to either increased resistance or increased left atrial pressure. Although this differential diagnosis is of obvious therapeutic relevance, guidelines about exercise stress studies of the pulmonary circulation have not been developed until now for lack of robust evidence allowing for a consensus on clearly defined cutoff values. Neither the pathophysiology of the exercise limitation nor the underlying mechanisms of the BPA - induced improvement were studied before. Therefore the aim of this study is to assess the hemodynamic effects of BPA treatment on the pressure-flow relationship in the pulmonary vasculature and the pulmonary vascular compliance. Furthermore, the investigators will explore possible differences in treatment effect across centers. Especially explore the timing of medical therapy vs balloon angioplasty. .

Interventions

DIAGNOSTIC_TESTInvasive exercise testing

Invasive hemodynamic exercise testing

Sponsors

Nagoya University
CollaboratorOTHER
Department of Pulmonary Circulation and Thromboembolic Diseases, Medical Center for Postgraduate Med
CollaboratorOTHER
Aarhus University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Exercise is added to the resting right heart catheterization.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-Patients with CTEPH or CTED eligible for balloon pulmonary angioplasty.

Exclusion criteria

-Patients unable to perform ergometer exercise

Design outcomes

Primary

MeasureTime frameDescription
Slope of mPA/CO after BPA6 months after last BPA sessionChange from Baseline in Slope of mean pulmonary artery pressure/cardiac output after BPA at 6 months

Secondary

MeasureTime frameDescription
Change in resting PVR after BPA6 months after last BPA sessionChange from Baseline in pulmonary vascular resistance (PVR) after BPA at 6 months
Change in 6 MWT after BPA6 months after last BPA sessionChange from Baseline in 6 minute walk test (MWT) after BPA at 6 months
Change in NT-proBNP after BPA6 months after last BPA sessionChange from Baseline in NT-proBNP after BPA at 6 months

Countries

Denmark, Japan, Poland

Contacts

Primary ContactMads J Andersen, MD, PhD
madsae@rm.dk+45784500000
Backup ContactJens Erik Nielsen-Kudsk, MD, Dm.Sci.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026